Hallucinations Under Psychedelics and in the Schizophrenia Spectrum: An Interdisciplinary and Multiscale Comparison December 1, 2020
Post-Marketing Safety Concerns with Esketamine: A Disproportionality Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System December 1, 2020
Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine November 30, 2020
Combining Ketamine, Brain Stimulation (rTMS) and Mindfulness Therapy (TIMBER) for Opioid Addiction November 30, 2020
Is ketamine an appropriate alternative to ECT for patients with treatment resistant depression? A systematic review November 30, 2020
Corticosterone as a Potential Confounding Factor in Delineating Mechanisms Underlying Ketamine’s Rapid Antidepressant Actions November 30, 2020
The Psychedelic Personality: Personality Structure and Associations in a Sample of Psychedelics Users November 29, 2020
Psychedelics as an emerging novel intervention in the treatment of substance use disorder: a review November 24, 2020
